Moratorium on Infectious Disease Research - What's the US Doing?

"The Obama administration announced the moratorium on Oct 17 to assess the risks and benefits of federally funded GOF research involving influenza, MERS (Middle East respiratory syndrome), and SARS (severe acute respiratory syndrome) viruses and to develop federal policies. The National Science Advisory Board for Biosecurity (NSABB) is playing a lead role in the review, which is expected to last almost a year. On Nov 25 the NSABB expressed concerns over the pause."

Click here to read the entire article that is shared from cidrap.umn.edu/

See also:

Dec 12 mBio editorial by Lipsitch and Inglesby

Dec 12 mBio editorial by Imperiale and Casadevall

Dec 12 mBio CDC commentary

Dec 12 mBio editorial by leading researchers

Dec 12 mBio editorial on GOF terminology

NAS notice of Dec 15-16 GOF symposium

Oct 17 CIDRAP News scan on GOF pause

Nov 25 CIDRAP News scan on NSABB meeting

Related articles

• CDC announces first case of Middle East Respiratory Syndrome Coronavirus infection (MERS) in the United States (workers-compensation.blogspot.com)
• To Quarantine or Not: 'Tis the Question (workers-compensation.blogspot.com)
• CDC Laboratory Safety Errors: The Dawn of the Planet of the Apes (workers-compensation.blogspot.com)
• US officials expected to announce Ebola screening at airports (workers-compensation.blogspot.com)
• US CDC Alerts Employees of Transportation Route Used by US Ebola Patient (workers-compensation.blogspot.com)